Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1

Journal of Infectious Diseases

Volumn 193, Issue 2, 2006, Pages 298-301

  Lajoie, Julie ^a,b   Hargrove, John ^e   Zijenah, Lynn S ^d   Humphrey, Jean H ^f   Ward, Brian J ^c   Roger, Michel ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^e ZVITAMBO Study Team   (Zimbabwe)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA E ANTIGEN; HLA G ANTIGEN;

ADULT; ALLELE; ARTICLE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROSEXUALITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ZIMBABWE;

EID: 30944442246     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498877     Document Type: Article

References (15)

1. Cohen GB, Gandhi RT, Davis DM, et al. The selective downregulation of class I major histocompatibility complex protein by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661-71.
2. Pizzato N, Derrien M, Lenfant F. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Hum Immunol 2004; 65:1389-96.
3. Lozano JM, Gonzalez R, Kindelan JM, et al. Monocytes and T lymphocytes in HIV-1 positive patients express HLA-G molecule. AIDS 2002; 16:347-51.
4. Nattermann J, Nischalke HD, Hofmeister V, et al. HIV-1 leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther 2005; 10:95-107.
5. Bonaparte MI, Barker E. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 2004; 104:2087-94.
6. Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M. Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 2004; 18:427-31.
7. Ober C, Aldrich C, Rosinsky B, et al. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998; 19:127-32.
8. Navarro F, Llano M, Bellon T, Colonna M, Geraghty D, Lopez-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29:277-83.
9. Matte C, Lacaille J, Zijenah L, Ward B, the ZVITAMBO Study Group, Roger M. HLA-G and HLA-E polymorphisms in an indigenous African population. Hum Immunol 2000; 61:1150-6.
10. Martin MP, Gao XJ, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-34.
11. Lopez-Vazquez A, Mina-Blanco A, Marinez-Borra J, et al. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 in a Zambian population. Hum Immunol 2005; 66: 285-9.
12. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE. HLA-E surface expression depends on the binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998; 160:4951-60.
13. Michaelsson J, Teixeira de Matos C, Achour A, et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002; 196:1403-14.
14. Pietra G, Romagnani C, Mazzarino P, et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 2003; 100:10896-901.
15. Strong RK, Holmes MA, Li P, et al. HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003; 278:5082-90.